Howard Jacob, Ph.D., Vice President and Head of Genomic Research at AbbVie, talks about the long term care potential offered by new human genetic sequencing technologies.
SPEAKER
S
Howard Jacob PhD.
Vice President and Head of Genomic Research, AbbVie
